Cargando…
Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS
The identification of activation pathways linked to antitumor T-cell polyfunctionality in long surviving patients is of great relevance in the new era of immunotherapy. We have recently reported that dacarbazine (DTIC) injected one day before peptide-vaccination plus IFN-α improves the antitumor lyt...
Autores principales: | Franzese, Ornella, Palermo, Belinda, Di Donna, Cosmo, Sperduti, Isabella, Ferraresi, Virginia, Stabile, Helena, Gismondi, Angela, Santoni, Angela, Nisticò, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910730/ https://www.ncbi.nlm.nih.gov/pubmed/27467927 http://dx.doi.org/10.1080/2162402X.2015.1114203 |
Ejemplares similares
-
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients
por: Palermo, Belinda, et al.
Publicado: (2018) -
T-cell repertoire diversity: friend or foe for protective antitumor response?
por: Porciello, Nicla, et al.
Publicado: (2022) -
Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study
por: Urbani, Francesca, et al.
Publicado: (2020) -
CD28/PD1 co-expression: dual impact on CD8(+) T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response
por: Palermo, Belinda, et al.
Publicado: (2023) -
Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients
por: Serana, Federico, et al.
Publicado: (2009)